Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Progyny, Inc. PGNY
$36.08
-$0.4 (-1.10%)
На 18:01, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
3569939934.00000000
-
week52high
46.50
-
week52low
25.67
-
Revenue
786913000
-
P/E TTM
106
-
Beta
1.51202600
-
EPS
0.30000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Jefferies | Buy | 02 дек 2021 г. | |
| Berenberg | Buy | 30 сент 2021 г. | |
| Barclays | Overweight | Overweight | 28 сент 2021 г. |
| Barclays | Overweight | Overweight | 25 авг 2021 г. |
| Barclays | Overweight | 12 авг 2021 г. | |
| Keybanc | Overweight | Overweight | 16 сент 2022 г. |
| Truist Securities | Buy | 07 сент 2022 г. | |
| JP Morgan | Overweight | Overweight | 18 ноя 2022 г. |
| SVB Leerink | Market Perform | Outperform | 05 янв 2023 г. |
| Keybanc | Overweight | Overweight | 19 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Anevski Peter | D | 1322820 | 32000 | 01 февр 2023 г. |
| Anevski Peter | D | 148414 | 8000 | 01 февр 2023 г. |
| Anevski Peter | D | 223093 | 32000 | 01 февр 2023 г. |
| Anevski Peter | A | 255093 | 32000 | 01 февр 2023 г. |
| Schlanger David J | D | 1132395 | 100000 | 01 февр 2023 г. |
| Schlanger David J | D | 74716 | 100000 | 01 февр 2023 г. |
| Schlanger David J | A | 174716 | 100000 | 01 февр 2023 г. |
| Anevski Peter | D | 1354820 | 735 | 31 янв 2023 г. |
| Anevski Peter | D | 156414 | 184 | 31 янв 2023 г. |
| Anevski Peter | D | 223093 | 735 | 31 янв 2023 г. |
Новостная лента
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research
30 янв 2023 г. в 13:33
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Progyny: Expect Fast Growth Despite A Weak Macro Backdrop
Seeking Alpha
29 янв 2023 г. в 04:24
There is a lack of effective solution in standard fertility benefit packages and PGNY is addressing this gap. PGNY's approach drives down the overall cost.
In Search of an Earnings Beat? Play These Top 5 Stocks
Zacks Investment Research
19 янв 2023 г. в 09:02
These top-ranked stocks are likely to beat on bottom line in their next releases. Tap Yum China (YUMC), Impinj (PI), Five Below (FIVE), Hologic (HOLX) and Progyny (PGNY).
7 Stocks With a Forward P/E of 25 to Run Away From
InvestorPlace
09 янв 2023 г. в 17:53
With a rough 2022 spilling into 2023, we're running into a broad list of stocks to avoid. Especially those in the tech space, where high-profile layoffs have picked up amid a severe slowdown in growth.
4 Unstoppable Multibaggers to Buy in 2023 and Hold for the Next Decade
The Motley Fool
27 дек 2022 г. в 05:57
Three-year revenue growth rates between 39% and 54% are projected, making these stocks prime multibagger candidates.